CME webinar: Heart Failure – Targeted Optimal Pharmacotherapy

Aug. 2024Education/Webinars

Please join us for a live, CME-accredited webinar on Wednesday, Oct. 30, from noon to 1 p.m. that will review targeted optimal pharmacotherapy in patients with heart failure.

At the end of this learning session, you will be able to:

  • Describe the pathophysiology and the physiological effects of key medication classes for heart failure.
  • Define the revisions in heart failure classification and guideline-directed medical therapy (GDMT) per the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure.
    • HFrEF (Quadruple therapy as the standard of care)
    • HFimpF
    • HFmrEF
    • HFpEF
  • Identify the risk and management of heart failure in people with diabetes.
  • Recognize the clinical benefits of GDMT for heart failure and the opportunities for improvement.
  • Describe the UPMC Health Plan GDMT heart failure initiative and clinical outcomes.

Presenters:

  • Nick DeGregorio, MD, MMM, FACP, AVP, Medicaid Services, UPMC Health Plan
  • Melinda Morgan, PharmD, Manager, Clinical Pharmacy, UPMC Health Plan

Register now. This webinar will be recorded.

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team. The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. The maximum number of hours awarded for this Continuing Pharmacy Education activity is 1.0 contact hour. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Provider is responsible for verifying CME eligibility.

Recent Announcements

CME Webinar Series: Introducing Physicians and their teams to Value-Based Health Care

Please join us for a new CME-accredited webinar series on value-based care. This series is designed to introduce practicing physicians and their teams to value-based health care. Over the course of six sessions, we will define the components of value and identify the tools necessary to deliver high-value care for a population.
Feb. 2026Education/Webinars

Bridging Smiles and Systems: Collaborative Care for Children with Chronic Conditions

Please join us for a live, CME-accredited and CEU-accredited webinar on May 13 from noon to 1p.m., that will explore the critical connection between oral health and pediatric chronic conditions such as diabetes, asthma, congenital heart disease, and ADHD.
Feb. 2026Education/Webinars

February 2026 UPMC for You and UPMC Community HealthChoices formulary update

Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted.
Feb. 2026Pharmacy Updates